跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 81,883 条关于
“Kidney diseases”
全部
81,883
临床试验
68,626
药物
1,256
机构
349
资讯
11,652
2年前
Novartis's Atrasentan Shows Promise with Projected $229M Revenue by 2033 for Kidney Diseases
去年
Sanofi Advances Multiple Phase 2 Trials Targeting Rare Kidney Diseases and Ulcerative Colitis
去年
Walden Biosciences Engages Former FDA Director to Advance WAL0921 Phase 2 Trial in Rare Kidney Diseases
去年
EMA Validates Aspaveli® Extension Application for Rare Kidney Diseases C3G and IC-MPGN
9个月前
Protalix and Secarna Partner to Develop AI-Powered Antisense Therapies for Rare Kidney Diseases
9个月前
GSK Partners with CAMP4 Therapeutics in $440M+ RNA Deal for Neurodegenerative and Kidney Diseases
2个月前
AstraZeneca and CSPC Pharma Expand Partnership with $1.77 Billion siRNA Deal for Kidney Diseases
上个月
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
去年
Aspaveli Demonstrates Sustained 68% Proteinuria Reduction in Phase 3 VALIANT Trial for Rare Kidney Diseases
前天
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
第 1 页,共 1166 页
上一页
下一页